These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Meningitis-associated hearing loss: protection by adjunctive antioxidant therapy. Klein M, Koedel U, Pfister HW, Kastenbauer S. Ann Neurol; 2003 Oct; 54(4):451-8. PubMed ID: 14520656 [Abstract] [Full Text] [Related]
3. Metformin mediates neuroprotection and attenuates hearing loss in experimental pneumococcal meningitis. Muri L, Le ND, Zemp J, Grandgirard D, Leib SL. J Neuroinflammation; 2019 Jul 27; 16(1):156. PubMed ID: 31351490 [Abstract] [Full Text] [Related]
6. Reduced spiral ganglion neuronal loss by adjunctive neurotrophin-3 in experimental pneumococcal meningitis. Demel C, Hoegen T, Giese A, Angele B, Pfister HW, Koedel U, Klein M. J Neuroinflammation; 2011 Jan 24; 8(1):7. PubMed ID: 21261959 [Abstract] [Full Text] [Related]
7. Adjunctive daptomycin attenuates brain damage and hearing loss more efficiently than rifampin in infant rat pneumococcal meningitis. Grandgirard D, Burri M, Agyeman P, Leib SL. Antimicrob Agents Chemother; 2012 Aug 24; 56(8):4289-95. PubMed ID: 22644021 [Abstract] [Full Text] [Related]
9. Adjuvant glycerol is not beneficial in experimental pneumococcal meningitis. Blaser C, Klein M, Grandgirard D, Wittwer M, Peltola H, Weigand M, Koedel U, Leib SL. BMC Infect Dis; 2010 Mar 30; 10():84. PubMed ID: 20353584 [Abstract] [Full Text] [Related]
10. Pneumococcal Meningitis Induces Hearing Loss and Cochlear Ossification Modulated by Chemokine Receptors CX3CR1 and CCR2. Hirose K, Li SZ, Gill R, Hartsock J. J Assoc Res Otolaryngol; 2024 Apr 30; 25(2):179-199. PubMed ID: 38472515 [Abstract] [Full Text] [Related]
11. MyD88-dependent immune response contributes to hearing loss in experimental pneumococcal meningitis. Klein M, Schmidt C, Kastenbauer S, Paul R, Kirschning CJ, Wagner H, Popp B, Pfister HW, Koedel U. J Infect Dis; 2007 Apr 15; 195(8):1189-93. PubMed ID: 17357057 [Abstract] [Full Text] [Related]
12. The Severity of Infection Determines the Localization of Damage and Extent of Sensorineural Hearing Loss in Experimental Pneumococcal Meningitis. Perny M, Roccio M, Grandgirard D, Solyga M, Senn P, Leib SL. J Neurosci; 2016 Jul 20; 36(29):7740-9. PubMed ID: 27445150 [Abstract] [Full Text] [Related]
13. The kynurenine pathway contributes to long-term neuropsychological changes in experimental pneumococcal meningitis. Too LK, McQuillan JA, Ball HJ, Kanai M, Nakamura T, Funakoshi H, McGregor IS, Hunt NH. Behav Brain Res; 2014 Aug 15; 270():179-95. PubMed ID: 24844751 [Abstract] [Full Text] [Related]
15. Interleukin-18 deficiency and its long-term behavioural and cognitive impacts in a murine model of pneumococcal meningitis. Too LK, Mitchell AJ, Yau B, Ball HJ, McGregor IS, Hunt NH. Behav Brain Res; 2014 Apr 15; 263():176-89. PubMed ID: 24503119 [Abstract] [Full Text] [Related]
18. Is adjunctive corticosteroid beneficial in pneumococcal meningitis in a region with high rates of resistance to penicillin and ceftriaxone? Moon SY, Chung DR, Kim SW, Chang HH, Lee H, Jung DS, Kim YS, Jung SI, Ryu SY, Heo ST, Moon C, Ki HK, Son JS, Kwon KT, Shin SY, Lee JS, Lee SS, Rhee JY, Kang CI, Peck KR, Song JH. J Neurol; 2012 Jul 15; 259(7):1453-60. PubMed ID: 22222857 [Abstract] [Full Text] [Related]